ACHV Award Disclosure
Halladay Benjamin · SEC Form 4 · Filed Oct 6, 2026
Award
Calculated transaction value
$0
Halladay Benjamin Chief Financial Officer
ACHV
Transaction date
Oct 5, 2026
Public filing date
Oct 6, 2026
Filing lag
Filed 1 day later
ACHV daily price context
Close on/before transaction
$7.01
Oct 5, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Unit (RSU) on Common Stock
- Quantity / price
- 200,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001953943-26-000004
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Achieve Life Sciences, Inc. ACHV | Award | Oct 5, 2026 | $0 |
| Achieve Life Sciences, Inc. ACHV Current | Award | Oct 5, 2026 | $0 |